UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

MiR-21 participates in LPS-induced myocardial injury by targeting Bcl-2 and CDK6

Inflammation research, 2022-02, Vol.71 (2), p.205-214

2022

Volltextzugriff (PDF)

Single cell transcriptomics identifies a unique adipose lineage cell population that regulates bone marrow environment

eLife, 2020-04, Vol.9

2020

Volltextzugriff (PDF)

Three-band triangular linearly frequency-modulated continuous-wave microwave photonic radar based on the gain-switched DFB laser

Optical and quantum electronics, 2024-06, Vol.56 (7), Article 1132

2024

Volltextzugriff (PDF)

Activin A marks a novel progenitor cell population during fracture healing and reveals a therapeutic strategy

eLife, 2023-12, Vol.12

2023

Volltextzugriff (PDF)

EGFR signaling is critical for maintaining the superficial layer of articular cartilage and preventing osteoarthritis initiation

Proceedings of the National Academy of Sciences - PNAS, 2016-12, Vol.113 (50), p.14360-14365

2016

Volltextzugriff (PDF)

Loncastuximab tesirine in relapsed/refractory diffuse large B-cell lymphoma: long-term efficacy and safety from the phase II LOTIS-2 study

Haematologica (Roma), 2024-04, Vol.109 (4), p.1184

2024

Volltextzugriff (PDF)

Periarticular Mesenchymal Progenitors Initiate and Contribute to Secondary Ossification Center Formation During Mouse Long Bone Development

Stem cells (Dayton, Ohio), 2019-05, Vol.37 (5), p.677-689

2019

Volltextzugriff (PDF)

Proteasome inhibitor bortezomib is a novel therapeutic agent for focal radiation‐induced osteoporosis

The FASEB journal, 2018-01, Vol.32 (1), p.52-62

2018

Volltextzugriff (PDF)

Risk factors for pulmonary cement embolism after percutaneous vertebroplasty and radiofrequency ablation for spinal metastases

Frontiers in oncology, 2023-05, Vol.13, p.1129658-1129658

2023

Volltextzugriff (PDF)

P1132: LONG‐TERM RESPONSES WITH LONCASTUXIMAB TESIRINE: UPDATED RESULTS FROM LOTIS‐2, THE PIVOTAL PHASE 2 STUDY IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA

HemaSphere, 2023-08, Vol.7 (S3), p.e402511c-n/a

2023

Volltextzugriff (PDF)

Skeletal Lesions in Primary Hyperparathyroidism

The American journal of the medical sciences, 2015-04, Vol.349 (4), p.321-327

2015

Volltextzugriff (PDF)

Final results of a phase 1 study of loncastuximab tesirine in relapsed/refractory B-cell non-Hodgkin lymphoma

Blood, 2021-05, Vol.137 (19), p.2634-2645

2021

Volltextzugriff (PDF)

Gli1 Defines a Subset of Fibro‐adipogenic Progenitors that Promote Skeletal Muscle Regeneration With Less Fat Accumulation

Journal of bone and mineral research, 2021-06, Vol.36 (6), p.1159-1173

2021

Volltextzugriff (PDF)

Early and Sustained Circulating Tumor DNA Response Dynamics after Loncastuximab Tesirine for Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Blood, 2023-11, Vol.142 (Supplement 1), p.3133-3133

2023

Volltextzugriff (PDF)

ABCL-351 LOTIS-5, an Ongoing, Phase 3 Randomized Study of Loncastuximab Tesirine With Rituximab (Lonca-R) Versus Immunochemotherapy in Patients With R/R DLBCL

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S473-S474

2024

Volltextzugriff (PDF)

LOTIS-5, an Ongoing, Phase 3, Randomized Study of Loncastuximab Tesirine With Rituximab (Lonca-R) Versus Immunochemotherapy in Patients With R/R DLBCL

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S216-S216

2024

Volltextzugriff (PDF)

Plasminogen Regulates Fracture Repair by Promoting the Functions of Periosteal Mesenchymal Progenitors

Journal of bone and mineral research, 2021-11, Vol.36 (11), p.2229-2242

2021

Volltextzugriff (PDF)

Characterization of molecular subtypes of melanoma and development of prognostic and immunotherapy-related genetic characteristics by ferroptosis gene analysis

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e21508-e21508

2022

Volltextzugriff (PDF)

Periosteal Mesenchymal Progenitor Dysfunction and Extraskeletally‐Derived Fibrosis Contribute to Atrophic Fracture Nonunion

Journal of bone and mineral research, 2019-03, Vol.34 (3), p.520-532

2019

Volltextzugriff (PDF)

Loncastuximab tesirine in previously treated diffuse large B-cell lymphoma: A plain language summary of the LOTIS-2 study

Future oncology (London, England), 2024-11, p.1-10

2024

Volltextzugriff (PDF)

Loading‐Induced Reduction in Sclerostin as a Mechanism of Subchondral Bone Plate Sclerosis in Mouse Knee Joints During Late‐Stage Osteoarthritis

Arthritis & rheumatology (Hoboken, N.J.), 2018-02, Vol.70 (2), p.230-241

2018

Volltextzugriff (PDF)

Loncastuximab tesirine in relapsed/refractory diffuse large B-cell lymphoma: long-term efficacy and safety from the phase 2 LOTIS-2 study

Haematologica (Roma), 2023-08

2023

Volltextzugriff (PDF)

ABCL-320 Initial Safety Run-In Results of the Phase 3 LOTIS-5 Trial: Novel Combination of Loncastuximab Tesirine With Rituximab (Lonca-R) Versus Immunochemotherapy in Patients With R/R DLBCL

Clinical lymphoma, myeloma and leukemia, 2022-10, Vol.22, p.S372

2022

Volltextzugriff (PDF)

Health-Related Quality of Life, Symptoms, and Tolerability of Loncastuximab Tesirine in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Clinical lymphoma, myeloma and leukemia, 2022-03, Vol.22 (3), p.158-168

2022

Volltextzugriff (PDF)

Analysis of short-term treatment with the phosphodiesterase type 5 inhibitor tadalafil on long bone development in young rats

American journal of physiology: endocrinology and metabolism, 2018-10, Vol.315 (4), p.E446-E453

2018

Volltextzugriff (PDF)

1 – 25 von 130

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(98)
Mit Volltextzugriff
(112)

Publikationsform

Sprache

Englisch
(106)
Chinesisch
(24)

Erscheinungsjahr

n.n

Thema

Science & Technology
(64)
Life Sciences & Biomedicine
(40)
Technology
(18)
Animals
(17)
Humans
(17)
Engineering
(15)
Mice
(13)
Physical Sciences
(13)
Engineering, Electrical & Electronic
(9)
Male
(8)
Bone Growth
(6)
Cell Biology
(6)
Endocrinology & Metabolism
(6)
Female
(6)
Bone Marrow
(5)
Chemistry
(5)
Fractures
(5)
Inflammation
(5)
Loncastuximab Tesirine
(5)
Mesenchyme
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

MiR-21 participates in LPS-induced myocardial injury by targeting Bcl-2 and CDK6

Single cell transcriptomics identifies a unique adipose lineage cell population that regulates bone marrow environment

Three-band triangular linearly frequency-modulated continuous-wave microwave photonic radar based on the gain-switched DFB laser

Activin A marks a novel progenitor cell population during fracture healing and reveals a therapeutic strategy

EGFR signaling is critical for maintaining the superficial layer of articular cartilage and preventing osteoarthritis initiation

Loncastuximab tesirine in relapsed/refractory diffuse large B-cell lymphoma: long-term efficacy and safety from the phase II LOTIS-2 study

Periarticular Mesenchymal Progenitors Initiate and Contribute to Secondary Ossification Center Formation During Mouse Long Bone Development

Proteasome inhibitor bortezomib is a novel therapeutic agent for focal radiation‐induced osteoporosis

Risk factors for pulmonary cement embolism after percutaneous vertebroplasty and radiofrequency ablation for spinal metastases

P1132: LONG‐TERM RESPONSES WITH LONCASTUXIMAB TESIRINE: UPDATED RESULTS FROM LOTIS‐2, THE PIVOTAL PHASE 2 STUDY IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA

Skeletal Lesions in Primary Hyperparathyroidism

Final results of a phase 1 study of loncastuximab tesirine in relapsed/refractory B-cell non-Hodgkin lymphoma

Gli1 Defines a Subset of Fibro‐adipogenic Progenitors that Promote Skeletal Muscle Regeneration With Less Fat Accumulation

Early and Sustained Circulating Tumor DNA Response Dynamics after Loncastuximab Tesirine for Relapsed/Refractory Diffuse Large B-Cell Lymphoma

ABCL-351 LOTIS-5, an Ongoing, Phase 3 Randomized Study of Loncastuximab Tesirine With Rituximab (Lonca-R) Versus Immunochemotherapy in Patients With R/R DLBCL

LOTIS-5, an Ongoing, Phase 3, Randomized Study of Loncastuximab Tesirine With Rituximab (Lonca-R) Versus Immunochemotherapy in Patients With R/R DLBCL

Plasminogen Regulates Fracture Repair by Promoting the Functions of Periosteal Mesenchymal Progenitors

Characterization of molecular subtypes of melanoma and development of prognostic and immunotherapy-related genetic characteristics by ferroptosis gene analysis

Periosteal Mesenchymal Progenitor Dysfunction and Extraskeletally‐Derived Fibrosis Contribute to Atrophic Fracture Nonunion

Loncastuximab tesirine in previously treated diffuse large B-cell lymphoma: A plain language summary of the LOTIS-2 study

Loading‐Induced Reduction in Sclerostin as a Mechanism of Subchondral Bone Plate Sclerosis in Mouse Knee Joints During Late‐Stage Osteoarthritis

Loncastuximab tesirine in relapsed/refractory diffuse large B-cell lymphoma: long-term efficacy and safety from the phase 2 LOTIS-2 study

ABCL-320 Initial Safety Run-In Results of the Phase 3 LOTIS-5 Trial: Novel Combination of Loncastuximab Tesirine With Rituximab (Lonca-R) Versus Immunochemotherapy in Patients With R/R DLBCL

Health-Related Quality of Life, Symptoms, and Tolerability of Loncastuximab Tesirine in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Analysis of short-term treatment with the phosphodiesterase type 5 inhibitor tadalafil on long bone development in young rats

Suchergebnisse filtern